Clinical data for GBM patients divided into specific survival times
| Survival group 1 <6 months | Survival group 2 6–12 months | Survival group 3 12–24 months | Survival group 4 >24 months | |
|---|---|---|---|---|
| Patient numbers | 8 | 13 | 15 | 8 |
| Median survival (months) (95% CI) | 4.0 (3.7 to 4.1) | 10.5 (7.2 to 13.9) | 14.2 (13.8 to 14.6) | 30.3 (27.7 to 32.9) |
| Median age (years) (range) | 66 (51–85) | 65 (38–76) | 60 (45–77) | 59 (24–70) |
| Location in the brain | ||||
| Frontal | 3 | 6 | 2 | 4 |
| Temporal | 3 | 4 | 7 | 2 |
| Parietal | – | 3 | 3 | 1 |
| Occipital | 1 | – | 1 | 1 |
| Multifocal | – | – | 1 | – |
| Unknown | 1 | – | 1 | – |
| Extent of surgery | ||||
| Total resection | 8 | 12 | 14 | 8 |
| Biopsy | 0 | 1 | 1 | 0 |
| Received concurrent treatment | ||||
| Yes | 3 | 12 | 15 | 8 |
| No | 5 | 1 | 0 | 0 |
| MGMT promoter methylation | ||||
| Yes | 2 | 1 | 3 | 3 |
| No | 6 | 11 | 9 | 2 |
| Not tested | 0 | 1 | 3 | 3 |
| EGFR amplification | ||||
| Yes | 1 | 2 | 4 | 1 |
| No | 2 | 2 | 3 | 2 |
| Not tested | 5 | 9 | 8 | 5 |
GBM, glioblastoma.